Bouvel Investment Partners’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Buy |
|
|||||
|
2025
Q1 | $1.02M | Sell |
|
|||||
|
2024
Q4 | $860K | Buy |
|
|||||
|
2024
Q3 | $1.02M | Sell |
|
|||||
|
2024
Q2 | $1.18M | Buy |
|
|||||
|
2024
Q1 | $1.49M | Buy |
|
|||||
|
2023
Q4 | $1.37M | Buy |
|
|||||
|
2023
Q3 | $949K | Buy |
|
|||||
|
2023
Q2 | $1.15M | Buy |
|
|||||
|
2023
Q1 | $903K | Buy |
|
|||||
|
2022
Q4 | $788K | Buy |
|
|||||
|
2022
Q3 | $1.22M | Buy |
|
|||||
|
2022
Q2 | $1.13M | Buy |
|
|||||
|
2022
Q1 | $1.15M | Buy |
|
|||||
|
2021
Q4 | $1.38M | Sell |
|
|||||
|
2021
Q3 | $2.06M | Sell |
|
|||||
|
2021
Q2 | $3.03M | Buy |
|
|||||
|
2021
Q1 | $2.28M | Sell |
|
|||||
|
2020
Q4 | $2.88M | Buy |
|